The company said net sales for Q1 2024 rose 6.2% to $5,065 million, and organic sales, which exclude the impact of foreign exchange, acquisitions and divestments, grew 9.8%. Gross profit margin was 60.0%, compared with 56.9% a year earlier.

1. 01

   The company said net sales for Q1 2024 rose 6.2% to $5,065 million, and organic sales, which exclude the impact of foreign exchange, acquisitions and divestments, grew 9.8%. Gross profit margin was 60.0%, compared with 56.9% a year earlier.

2. 02

   Colgate-Palmolive said diluted GAAP EPS for Q1 rose 84% to $0.83 from $0.45, and non-GAAP Base Business EPS rose 18% to $0.86 from $0.73. In Q1, GAAP results included adjustments of $267 million related to the ERISA litigation matter.

3. 03

   The company said GAAP operating profit for Q1 2024 rose 15% to $1,047 million from $909 million a year earlier, and operating profit margin was 20.7%. For the 3 months, net cash provided by operations was $681 million and free cash flow before dividends was $555 million.

4. 04

   The company raised its full-year net sales growth outlook to 2% to 5% from 1% to 4%, and its organic sales growth outlook to 5% to 7% from 3% to 5%. The net sales outlook includes a mid-single-digit negative impact from foreign exchange.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.